In parallel, the market taxonomy distinguishes several types of mobile diagnostic equipment, each influencing overall market volume. Portable X‑ray systems dominate the segment, offering digital radiography with battery operation and lightweight frames; their broad clinical utility drives the highest revenue contribution. Handheld ultrasound devices, valued for real‑time vascular and soft‑tissue assessment, represent a rapidly expanding niche due to decreasing sensor costs and AI‑enhanced image interpretation. Mobile computed tomography (CT) units provide limited‑slice, high‑resolution imaging suitable for emergency and intensive care settings, contributing a moderate share despite higher acquisition costs. Compact magnetic resonance imaging (MRI) platforms, though still emerging, address the need for on‑site neuro‑and musculoskeletal imaging where magnetic shielding constraints are manageable. Positron emission tomography (PET) mobile units serve specialized oncology and cardiology applications, representing the smallest yet high‑margin portion of the market. The relative weight of each type reflects the balance between clinical versatility, equipment cost, and regulatory reimbursement, thereby shaping the total market size.